Alendronate slows down aortic stenosis progression in osteoporotic patients: An observational prospective study

Alendronate slows down aortic stenosis progression in osteoporotic patients: An observational prospective study

Background: Aortic stenosis (AS) is the most common primary valvular disease. Currently, there is no pharmacological approach for the medical management of AS. We investigated the effect of osteoporosis therapy with alendronate on hemodynamic progression in patients concurrently affected by AS and o...

Full description

Bibliographic Details
Main Authors: Gholamhossein Alishiri, Kiyan Heshmat-Ghahdarijani, Mohammad Hashemi, Reihaneh Zavar, Maryam Moshkani Farahani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Research in Medical Sciences
Subjects:
alendronate
aortic stenosis
n-terminal-prohormone of brain natriuretic peptide
osteoporosis
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2020;volume=25;issue=1;spage=65;epage=65;aulast=Alishiri

Internet

http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2020;volume=25;issue=1;spage=65;epage=65;aulast=Alishiri

Similar Items